Skip to content
OpenCapital
Get started

Cabaletta Bio, Inc. CABA Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Revenue$1.6MDiluted EPS-$0.65In line
EPS estimate-$0.65

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$1.7M
EPS estimate-$0.37

Versus estimates

Revenue

Q4 2024$1.6M

Diluted EPS

Q1 2026-$0.39Beat by $0.02Q4 2025-$0.40Beat by $0.05Q3 2025-$0.44Beat by $0.05Q2 2025-$0.73Miss by $0.02Q1 2025-$0.71Miss by $0.04
Q4 2024-$0.65In line

Ask the moment Cabaletta Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cabaletta Bio, Inc. report Q4 2024 earnings?
Cabaletta Bio, Inc. (CABA) reported Q4 2024 earnings on March 31, 2025 before market open.
What were Cabaletta Bio, Inc.'s Q4 2024 revenue and EPS?
Cabaletta Bio, Inc. reported revenue of $1.6M and diluted EPS of $-0.65 for Q4 2024.
Did Cabaletta Bio, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.65 by $0.00.
Where can I find Cabaletta Bio, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-047201) directly on SEC EDGAR. The filing index links above go to sec.gov.